Two Co(II) coordination polymers exhibit picric acid sensing property and treatment activity in nonalcoholic fatty liver disease by reducing intestinal Escherichia coli counts

De-Feng Cai,Yuan-Shan Lu,Zhi-Hao Xing,Hong-Yu Chen,Xiao-Rong Liu,Dong-Li Ma
DOI: https://doi.org/10.1016/j.molstruc.2020.128832
IF: 3.841
2020-12-01
Journal of Molecular Structure
Abstract:<p>Two novel coordination polymers (CPs) based on the Co(II) of ([Co{1,3-bdc}{4-bpmh}]·2H<sub>2</sub>O)<sub>n</sub> (<strong>1</strong>, 1,3-H<sub>2</sub>bdc = 1,3-benzenedicarboxylic acid) and (Co[2-NH<sub>2</sub>BDC][4-bpm)]<sub><em>n</em></sub>·n[EtOH]) (<strong>2</strong>, 2-NH<sub>2</sub>-H<sub>2</sub>BDC = 2-aminoterephthalic acid) were prepared by reacting Co(NO<sub>3</sub>)<sub>2</sub>·6H<sub>2</sub>O with <em>N</em>,<em>N</em>-bis-pyridin-4-ylmethylene-hydrazine, a rigid, long, neutral bis-pyridyl ligand, in the presence of distinct dicarboxylate coligands under solvothermal conditions. Fluorescence sensing experiments revealed that in the fluorescence sensing of picric acid, complex <strong>2</strong> exhibited higher sensitivity and selectivity than complex <strong>1</strong>. The K<sub>sv</sub> of complex <strong>2</strong> is as high as 2.10 × 10<sup>5</sup> M<sup>−1</sup>, which was higher than that of previously reported CPs. The two compounds were evaluated for the treatment of nonalcoholic fatty liver disease. The triglyceride levels of liver cells treated with compound <strong>1</strong> or <strong>2</strong> were detected by using test kits. In addition, the CFU test was conducted to assess the inhibitory effect of compound <strong>1</strong> or <strong>2</strong> against <em>Escherichia coli</em>.</p>
chemistry, physical
What problem does this paper attempt to address?